Ourania Tatsis - Feb 10, 2023 Form 4 Insider Report for VERTEX PHARMACEUTICALS INC / MA (VRTX)

Role
EVP, Chief Reg. & Quality Off.
Signature
/s/ Christiana Stevenson, Attorney-in-Fact
Stock symbol
VRTX
Transactions as of
Feb 10, 2023
Transactions value $
-$1,380,804
Form type
4
Date filed
2/14/2023, 04:12 PM
Previous filing
Feb 3, 2023
Next filing
Feb 16, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VRTX Common Stock Tax liability -$405K -1.38K -1.96% $294.33 69K Feb 10, 2023 Direct
transaction VRTX Common Stock Tax liability -$893K -3K -4.34% $298.26 66K Feb 13, 2023 Direct
transaction VRTX Common Stock Sale -$592 -2 0% $295.84 66K Feb 13, 2023 Direct F1
transaction VRTX Common Stock Sale -$23.3K -78 -0.12% $298.11 66K Feb 13, 2023 Direct F1, F2, F3
transaction VRTX Common Stock Sale -$35.9K -120 -0.18% $298.98 65.8K Feb 13, 2023 Direct F1, F2, F4
transaction VRTX Common Stock Sale -$19.2K -64 -0.1% $299.88 65.8K Feb 13, 2023 Direct F1, F2, F5
transaction VRTX Common Stock Sale -$3.31K -11 -0.02% $300.79 65.8K Feb 13, 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Transaction made pursuant to Ms. Tatsis' company approved trading plan under Rule 10b5-1.
F2 Ms. Tatsis undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
F3 Open market sales reported on this line occurred at a weighted average price of $298.11 (range $297.51 to $298.50).
F4 Open market sales reported on this line occurred at a weighted average price of $298.98 (range $298.53 to $299.50).
F5 Open market sales reported on this line occurred at a weighted average price of $299.88 (range $299.62 to $300.53).